Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

IBDSL Biobank Project. Molecular Markers for Diagnosis and Therapy Response in IBD. A Prospective Population Based Biobank of Inflammatory Bowel Disease Patients in Zuid Limburg, The Netherlands.

NCT02130349 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT02130349
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02130349 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
IBDSL Biobank Project. Molecular Markers for Diagnosis and Therapy Response in IBD. A Prospective Population Based Biobank of Inflammatory Bowel Disease Patients in Zuid Limburg, The Netherlands.
Lead sponsor
Maastricht University Medical Center
Phase
Observational
Overall status
Unknown status
Start date
February 28, 2011
Completion date
December 31, 2020
Enrollment
5,000 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

crohns disease, ibd, ulcerative colitis